Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Midera Food Processing, Inc. (MFP)
USIndustrialsIndustrial - MachinerySnapshot 2026-11-04
$42.69+1.47%
Close 2026-11-04 · 1-day change
USIndustrialsIndustrial - MachinerySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
2.58 → 2.56 EPS · FY ending Dec 31, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for MFP yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain net leverage ratio below 3.0x | A supporting condition in Midera Food Processing, Inc.'s published investment case. The stated target is <=3.0. | Intact | net leverage ratio exceeds 3.0 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “Financial Position On June 29, 2026, the Company entered into a five-year, $1.0 billion credit agreement in connection with the Spin-off.” “As a result, the Company’s Net leverage ratio 1 was 1.3x based on last twelve months Estimated Standalone Adjusted EBITDA 1,2 .” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 17, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
MFP is an acquisition-supported industrial growth story, with a recently stated focus on organic growth and disciplined integration. The long-term thesis is still early and uncertain: the evidence shows initial sales growth, but organic growth was modest and recent earnings performance has been weak.
The evidence does not provide a valuation measure or a clear account of market expectations, so whether MFP looks cheap, fair, or expensive versus peers cannot be assessed. It reports low pricing fragility, meaning no identified pricing conditions are concentrating fragility; that does not establish what expectations are already reflected.
Near term, the next earnings report is a concern because MFP has missed in recent quarters, including its most recent one. In 2026 Q2, sales grew 13.2% year over year, while organic sales grew 1.2%; management also cited contributions from recent acquisitions and integration discipline. Its net leverage was 1.3 times against a stated 3.0 times target, while the new repurchase program has not yet produced reported repurchases.
The multi-year thesis depends on whether MFP can turn acquisition contributions into sustained organic growth while maintaining disciplined integration and its prudent capital structure. Near term, another guidance cut after the recent increase would damage management credibility, while continued strength or weakness among industrial bellwethers could support or weaken the sector backdrop.
MFP has evidence of sales growth, acquisition contributions, and manageable leverage, but recent misses, modest organic growth, and an industrial-sector headwind keep the 1-to-3-year thesis uncertain. The next results and guidance, along with execution on organic growth, are key tests. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Achieve margin expansion through operational efficiency | With a new CEO, Midera aims to improve operational efficiency and drive margin expansion. | Intact | EBITDA growth falls below 10% YoY | Ebitda: $28.6M FY2026-Q2; GAAP. Published target: >=10% YoY EBITDA growth. Annual target cannot be compared with a quarterly or TTM observation. Aug 18, 202628,600,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “Our updated guidance reflects continued margin expansion this year, 1 Non-GAAP financial measure.” “Estimated Standalone Adjusted EBITDA 1, 2 was $41.8 million in the second quarter of 2026, up $4.0 million as compared to $37.8 million in the prior year period, driven primarily by higher sales of aftermarket parts and services and higher equipment sales, including recent acquisitions, partially offset by the impact of cost inflation, including tariffs.” Delivery assessment Nov 4, 2026 |
Achieve revenue between $935 million and $965 million | Midera Food Processing is raising its revenue guidance to between $935 million and $965 million for FY26. | Improving | revenue falls below $935 million for FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$2.58 → $2.56 · observed estimates
$1.00B → $1.01B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-26 | $2.58 | $1,004,750,000 | 2 / 3 |
| 2026-08-27 | $2.58 | $1,004,750,000 | 2 / 3 |
| 2026-08-28 | $2.58 | $1,004,750,000 | 2 / 3 |
| 2026-08-29 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-08-30 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-08-31 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-01 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-02 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-03 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-04 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-05 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-06 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-07 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-08 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-09 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-10 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-11 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-12 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-13 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-14 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-15 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-16 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-17 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-18 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-19 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-20 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-21 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-22 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-23 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-24 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-25 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-26 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-27 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-28 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-29 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-09-30 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-01 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-02 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-03 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-04 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-05 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-06 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-07 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-08 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-09 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-10 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-11 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-12 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-13 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-14 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-15 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-16 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-17 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-18 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-19 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-20 | $2.58 | $1,004,750,000 | 3 / 3 |
| 2026-10-21 | $2.56 | $1,009,986,620 | 3 / 3 |
| 2026-10-22 | $2.56 | $1,009,986,620 | 3 / 3 |
| 2026-10-23 | $2.56 | $1,009,986,620 | 3 / 4 |
| 2026-10-24 | $2.56 | $1,009,986,620 | 4 / 4 |
| 2026-10-25 | $2.56 | $1,009,986,620 | 4 / 4 |
| 2026-10-26 | $2.56 | $1,009,986,620 | 4 / 4 |
| 2026-10-27 | $2.56 | $1,009,986,620 | 4 / 4 |
| 2026-10-28 | $2.56 | $1,009,986,620 | 4 / 4 |
| 2026-10-29 | $2.56 | $1,009,986,620 | 4 / 4 |
| 2026-10-30 | $2.56 | $1,009,986,620 | 4 / 4 |
| 2026-10-31 | $2.56 | $1,009,986,620 | 4 / 4 |
| 2026-11-01 | $2.56 | $1,009,986,620 | 4 / 4 |
| 2026-11-02 | $2.56 | $1,009,986,620 | 4 / 4 |
| 2026-11-03 | $2.56 | $1,009,986,620 | 4 / 4 |
| 2026-11-04 | $2.56 | $1,009,986,620 | 4 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.